bpc-157 safety humans adverse effects BPC-157: A Prohibited Peptide and an Unapproved Drug Found in Health and Wellness Products Should the FDA ease restrictions

Ozempic contains semaglutide as its sole active pharmaceutical ingredient

The FDA placed BPC-157 in 503A Category 2 in 2023, which blocked compounding pharmacies from preparing it

Compounded NAD+ and Sterility Many injectable NAD+ products encountered in wellness settings are compounded products

A subcutaneous (under-the-skin) vial format exists, but the dose volume math makes injection awkward at common doses

The teams support is unmatched

Small Molecule & Highly Potent Drug Product : Flexible production of complex oral and sterile dosage forms, including highly potent compounds, from clinical to commercial supply